PLX PHARMA INC's ticker is PLXP and the CUSIP is 72942A107. A total of 42 filers reported holding PLX PHARMA INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,071 | -99.2% | 12,620 | -60.3% | 0.00% | – |
| Q4 2021 | $255,000 | +107.3% | 31,802 | +132.8% | 0.00% | – |
| Q1 2021 | $123,000 | +310.0% | 13,658 | -30.6% | 0.00% | – |
| Q4 2018 | $30,000 | -78.1% | 19,671 | -42.0% | 0.00% | – |
| Q3 2018 | $137,000 | +95.7% | 33,934 | +196.4% | 0.00% | – |
| Q2 2017 | $70,000 | – | 11,450 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MSD Partners, L.P. | 1,875,000 | $4,556,000 | 0.28% |
| Ground Swell Capital, LLC | 48,931 | $119,000 | 0.22% |
| Park West Asset Management LLC | 1,473,218 | $3,580,000 | 0.20% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 62,673 | $152,000 | 0.07% |
| Eidelman Virant Capital | 27,000 | $63,000 | 0.04% |
| MBL Wealth, LLC | 52,000 | $126 | 0.03% |
| O'Brien Greene & Co. Inc | 22,340 | $54,000 | 0.02% |
| SHUFRO ROSE & CO LLC | 56,800 | $138,000 | 0.01% |
| GW&K Investment Management, LLC | 424,921 | $1,033,000 | 0.01% |
| EXANE DERIVATIVES | 6,575 | $15,974,000 | 0.01% |